Miles' KoGENate
Executive Summary
Price to distributors for the recombinant Factor VIII antihemophilic product is 82 cents per unit. KoGENate, approved Feb. 25, will compete against Baxter's Recombinate, which is marketed at an average wholesale price of $1.18 per unit. Miles said a portion of all hemophilia products will be set aside for distribution to indigent patients.